Chardan Healthcare Acquisition 2 Corp.

Chardan Healthcare Acquisition 2 Corp. (Nasdaq: CHAQ) is a blank-check company targeting the healthcare and life sciences sector, sponsored by Chardan Capital Markets, the New York-based investment bank with a long-standing life-sciences franchise. The SPAC completed its initial public offering in 2021 and, as of October 31, 2022, filed a Definitive Proxy Statement for Merger (DEFM14A) with the SEC, seeking shareholder approval for a proposed business combination with Renovacor Holdings, a clinical-stage cardiovascular gene therapy company. The filing represented the second healthcare-focused SPAC vehicle launched under the Chardan banner. Sign up at SpacDesk for full filing history, deal timelines, and analytics on CHAQ and hundreds of other SPAC vehicles.